News

The Council for Science and Technology has added to the advice on how to create healthier Britons.

Boosting innovation in the European Union may be a top political priority but heads of state and government from the 25 countries in the Union had little time for the topic at this week’s summit in Brussels.

The National Institute for Health Research is trying to spread the word about its role in knocking the NHS's R&D regime into the 21st century.

IBM has teamed up with seven universities in the USA, in a deal that might smooth over some conflicts.

In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.

Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.

Cambridge Biostability, a developer of temperature-stable liquid vaccines, agreed a joint venture with Panacea Biotec of India.

Anglo-Dutch antibody specialist PanGenetics BV has agreed a collaboration with Lay Line Genomics SpA of Rome, Italy, in the field of therapeutic antibodies for the treatment of pain.

Pharminox Ltd, a private oncology R&D company backed by IP Group, is to carry out joint research into novel small molecule chemotherapeutics with Schering-Plough.